Articles related to MEDICAL UNIVERSITY PRESS

Leqembi, a newly FDA-approved drug, has shown promising results in clinical trials, resulting in a 28% slower decline in Alzheimer’s patients compared to placebo. This equates to an additional four to five months of retained function.

A recent study from Fox Chase Cancer Center has revealed that as many as 23% of cystic renal masses may carry high-grade, or aggressive, disease. This finding challenges the prevailing assumption of their low-risk nature and underscores the need for more discerning diagnostic and treatment strategies.

With 40% of us expected to develop cancer in our lifetime and 20% likely to die from it, the need for advanced care is more urgent than ever. This collaboration between Dana-Farber and BIDMC represents a significant step towards meeting this need.

In her book, Kay Redfield Jamison explores how an active approach to adversity can help regenerate the mind. Drawing from sources as varied as Hippocrates, John Steinbeck, Sigmund Freud, and wartime diaries, she captures the chaos of war, the suffering it causes, and potential balms within reach.

In a recent study, researchers have discovered that gamma delta T cells in our intestines can influence our gut microbiome. This influence may extend to our brain functions and potentially impact stress-induced disorders such as depression.

The discovery that dopaminergic synapses become dysfunctional before neuronal death occurs could open up new avenues for potential therapies.